BC Baguley

Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs

CJ Lash, A E Li, Michael Rutland et al. · British Journal of Cancer · 1998 · 100 citations

Medicine, Oncology, Pharmacology +11

Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid

L‐M Ching, Z-F Xu, BH Gummer et al. · British Journal of Cancer · 1995 · 61 citations · Full text

Medicine, Oncology, Pharmacology +7

Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity

L‐M Ching, WL Browne, R Tchernegovski et al. · British Journal of Cancer · 1998 · 47 citations · Full text

Medicine, Oncology, Pharmacology +13

Production of tumour necrosis factor-α by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488)

Martin Philpott, WR Joseph, KE Crosier et al. · British Journal of Cancer · 1997 · 32 citations · Full text

Medicine, Immunology, Oncology +3